Gene · 4751
Papers2,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The pan-cancer analysis identified DIAPH3 as a diagnostic biomarker of clinical cancer. | Aging (Albany NY) | 2023 | 36750200 | PubTator, text mining | PubMed |
| SH2D4A promotes centrosome maturation to support spindle microtubule formation and mitotic progression. | Sci Rep | 2023 | 36739326 | PubTator, text mining | PubMed |
| Molecular characteristics, oncogenic roles, and relevant immune and pharmacogenomic features of NEK2 in gastric cancer. | Int Immunopharmacol | 2023 | 36738674 | PubTator, text mining | PubMed |
| Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | Mol Cell | 2023 | 36736316 | PubTator, text mining | PubMed |
| Phosphorylation of the prolyl isomerase Cyclophilin A regulates its localisation and release from the centrosome during mitosis. | Cell Cycle | 2023 | 36691345 | PubTator, text mining | PubMed |
| Comparing the transcriptome of developing native and iPSC-derived mouse retinae by single cell RNA sequencing. | Sci Rep | 2023 | 36681719 | PubTator, text mining | PubMed |
| DNA and RNA Alterations Associated with Colorectal Peritoneal Metastases: A Systematic Review. | Cancers (Basel) | 2023 | 36672497 | PubTator, text mining | PubMed |
| NEK6 Regulates Redox Balance and DNA Damage Response in DU-145 Prostate Cancer Cells. | Cells | 2023 | 36672191 | PubTator, text mining | PubMed |
| CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway. | Exp Hematol Oncol | 2023 | 36639822 | PubTator, text mining | PubMed |
| Identification and Characterization of mRNA and lncRNA Expression Profiles in Age-Related Hearing Loss. | Clin Exp Otorhinolaryngol | 2023 | 36634670 | PubTator, text mining | PubMed |
| Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria. | Cell Res | 2023 | 36627348 | PubTator, text mining | PubMed |
| Overexpression of the NEK9-EG5 axis is a novel metastatic marker in pathologic stage T3 colon cancer. | Sci Rep | 2023 | 36611072 | PubTator, text mining | PubMed |
| ETV2 Upregulation Marks the Specification of Early Cardiomyocytes and Endothelial Cells During Co-differentiation. | Stem Cells | 2023 | 36512477 | PubTator, text mining | PubMed |
| In silico analysis revealed the potential circRNA-miRNA-mRNA regulative network of non-small cell lung cancer (NSCLC). | Comput Biol Med | 2023 | 36495751 | PubTator, text mining | PubMed |
| Increased expression of HMMR in renal cell carcinoma is an independent prognostic factor. | Oncol Lett | 2023 | 36478897 | PubTator, text mining | PubMed |
| Bioinformatics driven discovery of small molecule compounds that modulate the FOXM1 and PPARA pathway activities in breast cancer. | Pharmacogenomics J | 2023 | 36424525 | PubTator, text mining | PubMed |
| Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling. | J Clin Invest | 2023 | 36394953 | PubTator, text mining | PubMed |
| NEK2 is associated with poor prognosis of clear cell renal cell carcinoma and promotes tumor cell growth and metastasis. | Gene | 2023 | 36370999 | PubTator, text mining | PubMed |
| Clinical characteristics of high myopia in female carriers of pathogenic RPGR mutations: a case series and review of the literature. | Ophthalmic Genet | 2023 | 36017691 | PubTator, text mining | PubMed |
| Exploration of the breast ductal carcinoma in situ signature and its prognostic implications. | Cancer Med | 2023 | 35880695 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4751/papers?page=16